NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-MD-24-011 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HD-25-004 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to participate in a research program cooperative agreement to support theOptimizing Health of Children and Adolescents with Perinatal HIV Exposure Initiative. The objective of this NOFO is to generate information needed to develop and to test interventions for the early detection and reduction of long-term effects of in utero/perinatal exposure toantiretroviral therapy (ART) and/or HIV among individuals who are HIV exposed but uninfected (IHEU).Investigators with innovative thinking and new approaches to address the public health issues facing IHEUs are encouraged to apply.
Notice NOT-AA-24-007 from the NIH Guide for Grants and Contracts
Notice NOT-AA-24-008 from the NIH Guide for Grants and Contracts
Notice NOT-AI-24-026 from the NIH Guide for Grants and Contracts
Notice NOT-AI-24-027 from the NIH Guide for Grants and Contracts
Notice NOT-DK-24-014 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-080 from the NIH Guide for Grants and Contracts
Notice NOT-DA-24-019 from the NIH Guide for Grants and Contracts
Notice NOT-AI-24-024 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-24-016 from the NIH Guide for Grants and Contracts. Reissue: RFA-NS-21-023 - The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.
Notice NOT-DK-24-017 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-081 from the NIH Guide for Grants and Contracts
Notice NOT-AT-24-037 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-24-161 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to encourage multidisciplinary investigators to submit applications developing exploratory, highly novel new approaches, or innovative applications of existing approaches to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease, by improving repeated measures across longer epochs of the lifespan to better predict outcomes at later ages. . Research can include healthy human participants of any age, specific clinical groups such those with cognitive, motor, or affective regulation challenges, and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation through this high risk, high reward funding mechanism to develop highly innovative ideas that either lack preliminary data or need additional preliminary data
Funding Opportunity PAR-24-160 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease. Research can include healthy human participants of any age, specific clinical groups such as those with cognitive, motor, or affective regulation challenges, and/or animal research on these domains of function. The studies can focus on longitudinal neuroanatomical or functional changes at any level, including genetics/genomics, single cells, connectomics, neural population activity patterns, and others. This funding opportunity is intended to encourage technological and conceptual innovation to improve repeated measures across longer epochs of the lifespan, to better predict outcomes at later ages.
Notice NOT-DK-24-018 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-24-031 from the NIH Guide for Grants and Contracts. Awarded activities will facilitate the translation of novel recording and modulation technologies that can be used to treat and/or diagnose central nervous system (CNS) diseases and disorders and to better understand the human CNS, from proof of concept up to the stage of readiness for first in human (FIH) studies. Technologies may incorporate any signal modality (e.g., electrical, optical, magnetic, acoustic) or a combination thereof. Diverse team-based applications that integrate appropriate domains of expertise are encouraged.
Notice NOT-TR-24-015 from the NIH Guide for Grants and Contracts
Notice NOT-TR-24-014 from the NIH Guide for Grants and Contracts